Acorda Therapeutics reported $29.62M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 136.21M 2.97M
Amgen AMGN:US $ 1.31B 79M
Anika Therapeutics ANIK:US $ 17.5M 489K
Aptinyx Inc APTX:US $ 4.93M 142K
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Cara Therapeutics CARA:US $ 5.88M 262K
Clovis Oncology CLVS:US $ 32.2M 722K
Cytokinetics CYTK:US $ 26.2M 5M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Insmed INSM:US $ 60.28M 3.1M
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Mannkind MNKD:US $ 17.22M 2.84M
Merck MRK:GR 1.38B 34M
Moderna Inc MRNA:US 168M 47M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Teva Pharmaceutical TEVA:IT 864M 32M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M